- Creatine, known for athletic performance enhancement, may boost the immune system's cancer-fighting ability by energizing dendritic cells, which activate killer T cells.
- UCLA research on mice and human cells shows creatine supplementation increases dendritic cell activity and ATP energy levels, slowing tumor growth in melanoma models and enhancing immune cell coordination.
- The findings suggest creatine could improve cancer immunotherapy and dendritic cell vaccine efficacy, but human trials are needed to confirm its benefits in patients.